1 Followers on Owler

NXT-Dx

provides end-to-end epigenetics services for IVD screening of biomarkers and clinical validation of DNA methylation signatures... Read more
OverviewCompetitorsNews & Insights

NXT-Dx

provides end-to-end epigenetics services for IVD screening of biomarkers and clinical validation of DNA methylation signatures... Read more
NXT-Dx CEO: Maarten Braspenning

CEO

Maarten Braspenning

CEO Approval Rating

85/100

2011

PrivateSubsidiary of Diagenode S.A.

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?

News

Aug 17, 2018
Genomeweb
NXT-Dx: Diagenode Acquires Epigenetics Firm Nxt-Dx

NXT-Dx Competitors

1Active Motif
2Epinomics
3CST
4EpiGentek
5Eurogentec
6Chronomics
7Bio-Techne
8Seahorse Bioscience
9Santa Cruz Biotechnology
10ACEA Biosciences
Unlock 15 + competitors

Trending Companies